Supplementary Figure S2 from Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer

2026 Open access

Read full text
Authors: Nofar Gumpert, Shira Sagie, Claudia Arnedo-Pac, Tomer Babu, Chen Weller, Abel Gonzalez-Perez, Yuan Wang, Lucas Michel Todó, Ronen Levy, Xi Chen, Polina Greenberg, Maria Dayan-Rubinov
+24 more Elizabeta Yakubovich, Talya Wasserman-Bartov, Mirie Zerbib, Jianhui Gong, Ryan James Rebernick, Almudena Tercero, Laura Agundez Muriel, Gil Benedek, Merav Kedmi, Roni Oren, Shifra Ben‐Dor, Yishai Levin, Olga G. Troyanskaya, Aslı D. Munzur, Alexander William Wyatt, Marcin P. Cieslik, David Alan Quigley, Eliezer M. Van Allen, Niroshana Anandasabapathy, Joaquı́n Mateo, Xinbo Yang, Francisco Martínez-Jiménez, Núria López-Bigas, Yardena Samuels
DOI: 10.1158/2159-8290.31296562
Cited by: 0

Abstract

Immunogenicity gating strategy of reactive CD8+ T-cells derived from healthy donor PBMCs

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Prostate Cancer Treatment and Research

Publication details

Publication date
9 February 2026
Language
EN